| Effects of Lisinopril, Irbesartan, and Amlodipine on the Thrombogenic Variables in the Early and Late Stages of the Treatment in Hypertensive Patients. | |
| | |
MedLine Citation:
|
PMID: 21967026 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Regulation of the fibrinolytic balance between plasminogen activators and inhibitors is modulated by the renin-angiotensin system (RAS). Impaired fibrinolytic function, characterized by increased plasminogen activator inhibitor type 1 (PAI-1) levels and decreased tissue plasminogen activator (t-PA) activity, has been found in patients with hypertension and may account in part for the increased risk of atherosclerosis and its clinical complications in these patients. In this regard, data from the literature indicate that different antihypertensive drugs may vary in their influence on fibrinolysis. Angiotensin-converting enzyme (ACE) inhibitors (ACE-I) have generally been shown to improve the fibrinolytic balance by reducing plasma PAI-1 levels. Calcium-channel blockers (CCB) have been reported to increase t-PA activity, and angiotensin receptor blockers (ARB) seem to be neutral in their effect. In the light of these data, this study aimed to compare the effects of ACE-I, ARB, and CCB on the fibrinolytic system in the early and late stages of the treatment in hypertensive patients. These data that the beneficial effect of RAS inhibition on fibrinolysis related to decrease in Ang II during early period of treatment. Amlodipine may also improve thrombogenic risk related to lowering the effect on increased platelet activation reflected by p-selectin. The greater improvement in the early and late stages of the fibrinolytic balance because of the combined action of RAS inhibition and Ca antagonism represents a further indication to the use of combinations of RAS inhibition (ACE-I or ARB) and CCB in the treatment of hypertension. |
| | |
Authors:
|
Ozlem Tiryaki; Celalettin Usalan; Hakan Buyukhatipoglu; Zeynel Abidin Sayiner; Hasan Kilisli |
Related Documents
:
|
14700596 - Hla class ii and class i polymorphism in venezuelan patients with myasthenia gravis. 3950136 - Multiple dermatofibromas in a patient with myasthenia gravis treated with prednisone an... 17240576 - Maxillary sinus tumours--a review of twenty-nine patients treated by maxillectomy appro... 21750646 - Treat ankylosing spondylitis with methazolamide. 18555706 - Clinical use of serum ca-125 levels in patients undergoing radical cystectomy for trans... 22340436 - Elevated baff levels in the cerebrospinal fluid of patients with neuro-behçet's diseas... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-10-3 |
Journal Detail:
|
Title: Clinical and experimental hypertension (New York, N.Y. : 1993) Volume: - ISSN: 1525-6006 ISO Abbreviation: - Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-4 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9305929 Medline TA: Clin Exp Hypertens Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Nephrology, School of Medicine, Gaziantep University , Gaziantep , Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A Slightly Low Hemoglobin Level Is Beneficially Associated with Arterial Stiffness in Japanese Commu...
Next Document: The Relationship between Resistant Hypertension and Arterial Stiffness.